Role of decentralized clinical trials in cancer drug development: Results from a survey of oncologists and patients

As a result of the unprecedented challenges imposed by the COVID-19 pandemic on enrollment to cancer clinical trials, there has been an urgency to identify and incorporate new solutions to mitigate these difficulties. The concept of decentralized or hybrid clinical trials has rapidly gained currency...

Descripción completa

Detalles Bibliográficos
Autores principales: de las Heras, Begoña, Daehnke, Adam, Saini, Kamal S, Harris, Melissa, Morrison, Kenneth, Aguilo, Ariel, Chico, Isagani, Vidal, Laura, Marcus, Robin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Quantitative Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136463/
https://www.ncbi.nlm.nih.gov/pubmed/35646380
http://dx.doi.org/10.1177/20552076221099997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136463/
https://www.ncbi.nlm.nih.gov/pubmed/35646380
http://dx.doi.org/10.1177/20552076221099997

Ejemplares similares